Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Simcere Pharma, like many US-listed China biopharmas, has...
BeiGene of Beijing out-licensed the ex-China rights for a...
Mindray Medical acquired a controlling stake in Shanghai...
Chindex accepted a buy-out offer of $24 per share from...
Zhejiang Hisun Pharma will collaborate with Ambrx of San...
IMS Health said China is “in a league of its...
CBT 200 Approaches 18-Month High. More details...
A List Of Players To Watch. More details...
Who Is Making The Drugs?. More details...
Deals, Products and New Trials Announced -- In the last...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
